Can 1 μg of Cosyntropin Be Used to Evaluate Adrenal Insufficiency in Critically Ill Patients?

Abstract

Spanish

French

OBJECTIVE:

To evaluate the utility of cosyntropin 1 μg in assessing adrenal function in critically ill patients.

DATA SOURCES:

A computerized literature search using MEDLINE, EMBASE, International Pharmaceutical Abstracts, and the Cochrane Database (1966–August 2004) was undertaken for trials evaluating cosyntropin 1 μg using the following search terms: adrenocorticotropin-releasing hormone (ACTH), cosyntropin, adrenal insufficiency, cortisol, corticosteroids, glucocorticoids, sepsis, septic shock, diagnosis, critically ill, intensive care, and critical care.

STUDY SELECTION AND DATA SYNTHESIS:

Identifying patients with sepsis with relative adrenal insufficiency (AI) using cosyntropin testing may identify those likely to benefit from corticosteroids. The results of 5 heterogeneous studies in non—intensive care unit (ICU) patients suggest that both 1 μg and 250 μg of cosyntropin stimulate similar cortisol responses and that testing using both doses correlates well with results from insulin tolerance testing. Some data from non-ICU patients suggest that the 1-μg test may be more sensitive to detect AI; 3 heterogeneous studies in ICU patients confirmed the improved sensitivity of the 1-μg test.

CONCLUSIONS:

Use of cosyntropin 1 μg should detect AI in all patients who would have been diagnosed using 250 μg. Unfortunately, all of the clinical trials evaluating the role of corticosteroids in septic shock that used the cosyntropin stimulation test administered 250 μg. Extrapolation of the existing guidelines to treat patients with septic shock testing positive for relative AI using the 1-μg test may provide effective therapy to appropriate patients not diagnosed by the 250-μg testing or may introduce additional adverse effects in patients who should not receive corticosteroids. Large-scale, head-to-head comparison data of steroid effectiveness after 1- and 250-μg ACTH stimulation tests are needed to expand upon these promising results.

Keywords

adrenal insufficiency corticosteroids cortisol cosyntropin

Get full access to this article

View all access options for this article.

References

Annane

Sebille

Charpentier

Bollaert

Francois

Korach

Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002;288: 862–71.

Manglik

Flores

Lubarsky

Fernandez

Chhibber

Tayek

Glucocorticoid insufficiency in patients who present to the hospital with severe sepsis: A prospective clinical trial. Crit Care Med 2003;31: 1668–75.

Coursin

Liddy

Wood

. Corticosteroid replacement in critical illness. Clin Pulm Med 2003;10: 278–88.

Briegel

Forst

Haller

Schelling

Kilger

Kuprat

Stress dose of hydrocortisone reverse hyperdynamic septic shock: A prospective, randomized, double-blind, single-center study. Crit Care Med 1999;27: 723–32.

Bollaert

Charpentier

Levy

Debouverie

Audibert

Larcan

Reversal of late septic shock with supraphysiological doses of hydrocortisone. Crit Care Med 1998;26: 645–50.

Meduri

Kanangat

Glucocorticoid treatment of sepsis and acute respiratory distress syndrome. Crit Care Med 1998;26: 630–3.

Matot

Sprung

. Corticosteroids in septic shock: Resurrection of the last rites. Crit Care Med 1998;26: 627–30.

Marik

Zaloga

. Adrenal insufficiency in the critically ill: A new look at an old problem. Chest 2002;122: 1784–96.

Cooper

Stewart

. Current concepts: Corticosteroid insufficiency in acutely ill patients. N Engl J Med 2003;348: 727–34.

10.

Arlt

Allolio

Adrenal insufficiency. Lancet 2003;361: 1881–93.

11.

Marik

Zaloga

Prognostic value of cortisol response in septic shock. JAMA 2000;284: 308–9.

12.

Jurney

Cockrell

Lindberg

Lamiell

Wade

. Spectrum of serum cortisol response to ACTH in ICU patients: Correlation with degree of illness and mortality. Chest 1987;92: 292–5.

13.

Annane

Sebille

Troche

A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 2000;283: 1038–45.

14.

Zaloga

Marik

Endocrine and metabolic dysfunction syndromes in the critically ill. Crit Care Clin 2001;17: 25–41.

15.

Zaloga

. Sepsis-induced adrenal deficiency syndrome. Crit Care Med 2001;29: 688–90.

16.

Dorin

Qualls

Crapo

. Diagnosis of adrenal insufficiency. Ann Intern Med 2003;139: 194–204.

17.

Oelkers

Current concepts: Adrenal insufficiency. N Engl J Med 1996;335: 1206–12.

18.

Rothwell

Lawler

. Prediction of outcome in intensive care patients using endocrine parameters. Crit Care Med 1995;23: 78–83.

19.

Chernow

Rainey

Lake

Endogenous and exogenous catecholamines in critical care medicine. Crit Care Med 1982;10: 409–16.

20.

Hart

Stanford

Ziegler

Lake

Chernow

Catecholamines: Study of interspecies variation. Crit Care Med 1989;17: 1203–18.

21.

Rivers

Gaspari

Saad

Mlynarek

Fath

Horst

Adrenal insufficiency in high-risk surgical ICU patients. Chest 2001;119: 889–96.

22.

Hoen

Asehnoune

Brailly-Tibard

Mazoit

Benhamou

Moine

Cortisol response to corticotropin stimulation in trauma patients. Anesthesiology 2002;97: 807–13.

23.

Annane

Bessissant

Sebille

Lesieur

Mathieu

Raphael

Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve. Br J Clin Pharmacol 1998;46: 589–97.

24.

Marik

Zaloga

. Adrenal insufficiency during septic shock. Crit Care Med 2003;31: 141–5.

25.

Dickstein

Shechner

Nicholson

Rosner

Shen-Orr

Adawi

Adrenocorticotropin stimulation test: Effects of basal cortisol level, time of day, and suggested new sensitive low dose test. J Clin Endocrinol Metab 1991;72: 773–8.

26.

Darmon

Dadoun

Frachebois

Velut

Boullu

Dutour

On the meaning of low-dose ACTH (1–24) tests to assess functionality of the hypothalamic-pituitary-adrenal axis. Eur J Endocrinol 1999;140: 51–5.

27.

Abdu

Neary

Clayton

Comparison of the low dose short synacthen test (1μg), the conventional dose short synacthen test (250 μg), and the insulin tolerance test for assessment of the hypothalamic-pituitary-adrenal axis in patients with pituitary disease. J Clin Endocrinol Metab 1999;84: 838–43.

28.

Rasmuson

Olsson

Hagg

A low-dose ACTH test to assess the function of the hypothalamic-pituitary-adrenal axis. Clin Endocrinol 1996;44: 151–6.

29.

Nye

Grice

Hockings

Strakosch

Crosbie

Walters

Comparison of adrenocorticotropin (ACTH) stimulation test and insulin hypoglycemia in normal humans: Low dose, standard high dose, and 8-hour ACTH-(1–24) infusion tests. J Clin Endocrinol Metab 1999;84: 3648–55.

30.

Weintrob

Sprecher

Josefsberg

Weininger

Aurbach-Klipper

Lazard

Standard and low-dose short adrenocorticotropin test compared with insulin-induced hypoglycemia for assessment of the hypothalamic-pituitary-adrenal axis in children with idiopathic multiple pituitary hormone deficiencies. J Clin Endocrinol Metab 1998;83: 88–92.

31.

Mayenknecht

Diederich

Bahr

Plockinger

Oelkers

Comparison of low and high dose corticotropin stimulation tests in patients with pituitary disease. J Clin Endocrinol Metab 1998;83: 1558–62.

32.

Marik

Kiminyo

Zaloga

. Adrenal insufficiency in critically ill patients with human immunodeficiency virus. Crit Care Med 2002;30: 1267–73.

33.

Yamashita

Drynan

Guest

Comparison of low-dose 1 μg with conventional dose cosyntropin 250 μg for adrenal insufficiency testing in critical illness (abstract). Crit Care Med 2001;29(suppl):A164.

34.

Smoylar

Tirado-Berbardini

Landman

Comparison of 1 μg and 250 μg corticotropin stimulation tests for the evaluation of adrenal function in patients with acquired immunodeficiency syndrome. Metabolism 2003;52: 647–51.